反応式
Cl[C:2]1[CH:7]=[N:6][N:5]([CH3:8])[C:4](=[O:9])[CH:3]=1.[I:10][C:11]1[N:12]=[C:13]([CH3:16])[NH:14][CH:15]=1.C(=O)([O-])[O-].[Cs+].[Cs+]>CN(C=O)C>[I:10][C:11]1[N:12]=[C:13]([CH3:16])[N:14]([C:2]2[CH:7]=[N:6][N:5]([CH3:8])[C:4](=[O:9])[CH:3]=2)[CH:15]=1参加物
5
反応条件
- 温度
- 45 °C
実験手順
To a solution of 160 mg (1.11 mmol) of 5-chloro-2-methyl-2H-pyridazin-3-one (CAS: [14628-34-3]), 230 mg (1.11 mmol) of 4-iodo-2-methyl-1H-imidazole (CAS: [73746-45-9]), in 3.5 ml of dry DMF were added 721 mg (2.21 mmol) of cesium carbonate. The suspension was stirred for 30 min at 45° C., then for 3 h at 65° C. and allowed to cool. The cristallised product is filtered off, washed with ethyl acetate and dried in vaccuo to yield 250 mg (0.791 mmol, 71%) of the title compound as a crystalline light yellow solid, MS: m/e=316.9 (M+H+).
後処理
- waitfor 3 h at 65° C.
- temperatureto cool
- filtrationThe cristallised product is filtered off
- washwashed with ethyl acetate
- customdried in vaccuo
出典と根拠
- ORDレコード
- ord-fb33a895c6bf45c08330c5a5f7d30a76
- 出典データセット
- uspto-grants-2012_12
- 特許番号
- US08334287B2
関連ノート
読み込み中…